University of Waterloo
uwaterloo.caTotal trials
89
Active
10
Phase 3
4
Total enrollment
21,582
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Propylene glycol 0.6% | — | — | — | — | — | 1 |
Next readouts
- 2027-05-23
Top conditions
- Myopia10
- Dry Eye8
- Osteoporosis6
- Malnutrition4
- Ametropia3
- Dementia3
- Cancer3
- Keratoconus3
Frequently asked questions about University of Waterloo
- How many clinical trials does University of Waterloo have on ClinicalTrials.gov?
- University of Waterloo is listed as the lead sponsor on 89 clinical trials in ClinicalTrials.gov, 10 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Waterloo's trials are in Phase 3?
- 4 of University of Waterloo's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does University of Waterloo focus on?
- University of Waterloo's most-studied conditions on ClinicalTrials.gov are Myopia, Dry Eye, Osteoporosis, Malnutrition, Ametropia.
- When are University of Waterloo's next clinical trial readouts?
- University of Waterloo has 1 upcoming primary-completion readout tracked here; the soonest is “Comparison of Ocular Lubricants in People With Symptoms of Dry Eye”, expected around 2027-05-23.